浅谈分子生物基因在原发性高血压中的作用

The Role of Molecular Biogenes in Essential Hypertension

原发性高血压是由遗传和环境等多方面影响的遗传相关的慢性非传染性疾病,随着它的高发病率被全世界高度关注。流行病学调查显示,原发性高血压患病人群已趋年轻化。高血压作为心血管疾病的首要危险因素及病因,具有较高发病率、致残率、致死率。因此,原发性高血压发病机制的研究就显得尤为重要,本文通过对原发性高血压分子生物基因方面的研究进展进行相关阐述,了解其在高血压疾病中的运用,更好进行早期发现、干预、诊疗,对降低原发性高血压发病率,减少心血管疾病发生有着重要意义。

Essential hypertension is a chronic non-infectious disease related to heredity, which is affected by heredity, environment and other aspects. With its high incidence rate, it has been highly concerned all over the world. Epidemiological surveys show that the population with primary hypertension is becoming younger. Hypertension, as the primary risk factor and cause of cardiovascular disease, has a high incidence rate, disability rate and mortality rate. Therefore, the research on the patho-genesis of essential hypertension is particularly important. This article describes the research pro-gress in molecular biological genes of essential hypertension, understands its application in hyper-tension, and better carries out early detection, intervention, diagnosis and treatment, which is of great significance to reduce the incidence rate of essential hypertension and reduce the incidence of cardiovascular diseases.